Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1998 | 06-1998 | 03-1998 | 12-1997 | 09-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,230 | 2,170 | 100 | 438 | 1,348 |
| Receivables | 0 | 2 | 10 | 1 | 88 |
| Other current assets | 10 | 28 | 50 | 51 | 130 |
| TOTAL | $2,240 | $2,200 | $160 | $490 | $1,566 |
| Non-Current Assets | |||||
| PPE Net | 1,000 | 1,000 | 1,040 | 422 | 673 |
| Other Non-Current Assets | 530 | 550 | 510 | 0 | 0 |
| TOTAL | $1,530 | $1,550 | $1,550 | $422 | $673 |
| Total Assets | $3,040 | $3,040 | $1,050 | $1,447 | $2,376 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 380 | 390 | 390 | 0 | 0 |
| Accrued Expenses | 0 | 10 | 20 | N/A | N/A |
| Other current liabilities | 0 | 0 | 50 | N/A | N/A |
| TOTAL | $470 | $490 | $600 | $706 | $348 |
| Non-Current Liabilities | |||||
| TOTAL | $50 | $70 | $110 | $N/A | $N/A |
| Total Liabilities | $520 | $560 | $720 | $706 | $348 |
| Shareholders' Equity | |||||
| Common Shares | 30 | 30 | 1,490 | 1,304 | 1,280 |
| Retained earnings | -22,380 | -21,570 | -20,640 | N/A | N/A |
| Other shareholders' equity | 0 | 10 | 10 | -705 | 592 |
| TOTAL | $2,510 | $2,480 | $330 | $599 | $1,872 |
| Total Liabilities And Equity | $3,030 | $3,040 | $1,050 | $1,305 | $2,220 |